Tg Therapeutics (TGTX) Inventory Average (2023 - 2026)

Tg Therapeutics' Inventory Average history runs 4 years deep, the most recent figure standing at $127.3 million for Q1 2026.

• In Q1 2026, Inventory Average fell 5.07% year-over-year to $127.3 million; the TTM figure through Mar 2026 stood at $127.3 million (down 5.07% YoY), while the FY2025 annual figure was $118.0 million, up 57.07% from the prior year.
• Inventory Average was $127.3 million for Q1 2026 at Tg Therapeutics, down from $136.3 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $156.5 million in Q2 2025 to a low of $28.7 million in Q2 2023.
• Historically, Inventory Average has averaged $93.4 million across 4 years, with a median of $90.3 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Inventory Average surged 176.67% in 2024, then fell 5.07% in 2026.
• A 4-year view of Inventory Average shows it stood at $36.7 million in 2023, then soared by 165.93% to $97.6 million in 2024, then jumped by 39.67% to $136.3 million in 2025, then retreated by 6.58% to $127.3 million in 2026.
• The last three Inventory Average figures came in at $127.3 million (Q1 2026), $136.3 million (Q4 2025), and $151.1 million (Q3 2025), per Business Quant data.